Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03475550 · ClinicalTrials.gov registry record · NA
Managing Side Effects in Clinical Practice
A NA study of Functional Gastrointestinal Disorders, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT03475550: Completed NA study of Functional Gastrointestinal Disorders, sponsored by Beth Israel Deaconess Medical Center.
NCT03475550 is a NA study of Functional Gastrointestinal Disorders that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 31 participants, below the 235-participant average among 5 other Functional Gastrointestinal Disorders trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03475550, a NA study of Functional Gastrointestinal Disorders, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a quality improvement health services study in the Division of Gastroenterology at Beth Israel Deaconess Medical Center (BIDMC).
Primary Outcome
Visual Analog Scale of reported benefit from the drug (0-10)
Conditions Studied
Interventions
- OTHER Standard of Care
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2017-05-22 |
| Est. Completion | 2020-09-30 |
| Phase | NA |
What the finished NCT03475550 record still lists
NCT03475550 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 235-participant average among 5 other Functional Gastrointestinal Disorders trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Functional Gastrointestinal Disorders appearing as the primary indexed condition, and to 1 intervention - of which Standard of Care is the first listed.
NCT03475550 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03475550 about?
NCT03475550 is a clinical study titled "Managing Side Effects in Clinical Practice". This is a quality improvement health services study in the Division of Gastroenterology at Beth Israel Deaconess Medical Center (BIDMC).
What is the current status of trial NCT03475550?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2017-05-22. Estimated completion is 2020-09-30.
What conditions does trial NCT03475550 study?
This clinical trial studies the following conditions: Functional Gastrointestinal Disorders.
What interventions are being tested in trial NCT03475550?
The interventions under investigation include: Standard of Care (OTHER).
Who is sponsoring clinical trial NCT03475550?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03475550 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Functional Gastrointestinal Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?
RECRUITING · NA
-
Auricular Vagal Nerve Stimulation for Hypermobile Ehlers-Danlos Syndrome
RECRUITING · NA
-
Defining Adolescent Nausea Through Brain Imaging and Neurostimulation Response
COMPLETED · NA
-
Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease
RECRUITING
-
BSGM to Evaluate Patients With GI Symptoms
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI